These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15771229)

  • 1. Vitamin D3-based conjugates for topical treatment of psoriasis: synthesis, antiproliferative activity, and cutaneous penetration studies.
    Ben-Shabat S; Benisty R; Wormser U; Sintov AC
    Pharm Res; 2005 Jan; 22(1):50-7. PubMed ID: 15771229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamine D analogue-based therapies for psoriasis.
    O'Neill JL; Feldman SR
    Drugs Today (Barc); 2010 May; 46(5):351-60. PubMed ID: 20517536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of psoriasis with calcipotriol and other vitamin D analogues.
    Kragballe K
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):1001-8. PubMed ID: 1479078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion.
    Fujiyama T; Ito T; Umayahara T; Ikeya S; Tatsuno K; Funakoshi A; Hashizume H; Tokura Y
    J Allergy Clin Immunol; 2016 Aug; 138(2):517-528.e5. PubMed ID: 27315769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of the keratinizing skin disorder, psoriasis, by topical vitamin D3].
    Takahashi H; Iizuka H
    Clin Calcium; 2004 Oct; 14(10):129-32. PubMed ID: 15577145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on vitamin D3 analogues in the treatment of psoriasis.
    van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 1998; 11(1):2-10. PubMed ID: 9603664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin D3 and its analogues: a new age in the treatment of psoriasis vulgaris?].
    Messay B; Schneider I; Mojzes J
    Orv Hetil; 1994 Nov; 135(48):2647-50. PubMed ID: 7808739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium effects and systemic exposure of vitamin D3 analogues after topical treatment of active vitamin D3-containing ointments in rats.
    Hosomi A; Hirabe M; Tokuda T; Nakamura H; Amano T; Okamoto T
    Eur J Pharmacol; 2016 Oct; 788():98-103. PubMed ID: 27321871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D3 derivatives, alone or in combination with glucocorticoids, suppress streptococcal pyrogenic enterotoxin A-stimulated proliferation of peripheral blood mononuclear cells in patients with psoriasis.
    Usui K; Okubo Y; Hirano T; Tsuboi R
    J Dermatol; 2017 May; 44(5):567-572. PubMed ID: 28012189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 analogues.
    Kragballe K
    Dermatol Clin; 1995 Oct; 13(4):835-9. PubMed ID: 8785887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcipotriol delivery into the skin with PEGylated liposomes.
    Knudsen NØ; Rønholt S; Salte RD; Jorgensen L; Thormann T; Basse LH; Hansen J; Frokjaer S; Foged C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):532-9. PubMed ID: 22538098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D3 analogues.
    Fogh K; Kragballe K
    Clin Dermatol; 1997; 15(5):705-13. PubMed ID: 9313969
    [No Abstract]   [Full Text] [Related]  

  • 13. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitamin D3 for external application--history of development and clinical application].
    Tarutani M
    Clin Calcium; 2004 Oct; 14(10):124-8. PubMed ID: 15577144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcipotriol. A new topical antipsoriatic.
    Kragballe K; Iversen L
    Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical vitamin D3 derivatives impair the epidermal permeability barrier in normal mouse skin.
    von Brenken S; Jensen JM; Fartasch M; Proksch E
    Dermatology; 1997; 194(2):151-6. PubMed ID: 9094464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
    Koli K; Keski-Oja J
    J Invest Dermatol; 1993 Nov; 101(5):706-12. PubMed ID: 8228332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D analogues in the treatment of psoriasis.
    Kragballe K
    J Cell Biochem; 1992 May; 49(1):46-52. PubMed ID: 1644854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903).
    Kragballe K
    Arch Dermatol; 1989 Dec; 125(12):1647-52. PubMed ID: 2531570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.